Skip to main content
Record
Title
Epidermal growth factor receptor (EGFR) and the estrogen receptor modulator amplified in breast cancer (AIB1) for predicting clinical outcome after adjuvant tamoxifen in breast cancer.
Type
Journal Article
Publ. year
2008
Author/s
Dihge, Looket; Bendahl, Pär-Ola; Grabau, Dorthe; Isola, Jorma et al.
Department/s
Breastcancer-genetics; Surgery (Lund); Tumor microenvironment
In LUP since
2016-04-01
Downloads

Total This Year This Month
440 3 0
Downloads per country

United States of America 211 (48%)
China 75 (17%)
Germany 38 (9%)
Russian Federation 13 (3%)
Sweden 12 (3%)
Denmark 7 (2%)
Hong Kong (China) 6 (1%)
France 5 (1%)
Canada 5 (1%)
South Korea 5 (1%)
India 5 (1%)
United Kingdom of Great Britain and Northern Ireland 5 (1%)
Romania 5 (1%)
Lithuania 4 (1%)
Japan 4 (1%)
South Africa 3 (1%)
Ukraine 3 (1%)
Czechia 3 (1%)
Hungary 3 (1%)
Pakistan 3 (1%)
Poland 2 (0%)
Brazil 2 (0%)
Malaysia 2 (0%)
Serbia 1 (0%)
Taiwan (China) 1 (0%)
Unknown 1 (0%)
Chile 1 (0%)
European Union location 1 (0%)
Argentina 1 (0%)
Macao 1 (0%)
Viet Nam 1 (0%)
Portugal 1 (0%)
Asia-Pacific location 1 (0%)
Ireland 1 (0%)
Ethiopia 1 (0%)
Sudan 1 (0%)
Italy 1 (0%)
Finland 1 (0%)
Saudi Arabia 1 (0%)
Egypt 1 (0%)
Israel 1 (0%)
Turkey 1 (0%)
About
The download statistics shown here have been collected since the launch of LUP in October 2007 and are updated every night. Statistics are available for all records with open access fulltexts. Efforts have been made to exclude downloads by robots and track irregular download activities.

About accessibility

Disclaimer
The information on downloads per country is based on the geolocation of IP addresses and may not be completely accurate. The statistics presented here may also change retroactively when the calculation process is improved to provide more accurate results.

Statistics Last Updated
Thu Apr 25 08:41:02 2024